Detalles de la búsqueda
1.
Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women: Scoping review and international consensus recommendations.
BJOG
; 130(12): 1437-1450, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37132126
2.
Cancer worry among BRCA1/2 pathogenic variant carriers choosing surgery to prevent tubal/ovarian cancer: course over time and associated factors.
Support Care Cancer
; 30(4): 3409-3418, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34997316
3.
Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategy.
Gynecol Oncol
; 163(2): 371-377, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34456057
4.
Changes in Sex Steroids and Relation With Menopausal Complaints in Women Undergoing Risk-reducing Salpingo-oophorectomy.
J Endocr Soc
; 6(6): bvac069, 2022 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35592509
5.
The effect of hormone therapy on breast density following risk-reducing salpingo-oophorectomy in women with an increased risk for breast and ovarian cancer.
Menopause
; 28(11): 1307-1312, 2021 08 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34374687
6.
Association of Salpingectomy With Delayed Oophorectomy Versus Salpingo-oophorectomy With Quality of Life in BRCA1/2 Pathogenic Variant Carriers: A Nonrandomized Controlled Trial.
JAMA Oncol
; 7(8): 1203-1212, 2021 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34081085
7.
Breast cancer and climacteric complaints: weighing up risks of hormone therapy against quality of life.
Eur J Obstet Gynecol Reprod Biol
; 134(2): 143-6, 2007 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17574325
8.
Hormone replacement therapy and surveillance considerations.
Maturitas
; 43 Suppl 1: S57-67, 2002 Aug 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-12361889
Resultados
1 -
8
de 8
1
Próxima >
>>